Cita APA

Pallàs i Llibería, M., Vázquez Cruz, S., Sanfeliu i Pujol, C., Galdeano Cantador, C., & Griñán Ferré, C. (2020). Soluble epoxide hydrolase inhibition to face neuroinflammation in Parkinson's disease: A new therapeutic strategy.

Citación estilo Chicago

Pallàs i Llibería, Mercè, Santiago Vázquez Cruz, Coral Sanfeliu i Pujol, Carlos Galdeano Cantador, y Christian Griñán Ferré. Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy. 2020.

Cita MLA

Pallàs i Llibería, Mercè, et al. Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy. 2020.